Hyperhomocyst(e)inaemia in children with chronic renal failure

Background. Hyperhomocyst(e) inaemia has been identified as a significant risk factor for the occurrence of atherosclerosis in adults with chronic renal failure. Because of its presumed direct toxic effect on the vascular wall, long-standing hyperhomocyst (e)inaemia in children with chronic renal failure might have an important influence on their risk of future development of atherosclerosis. Hitherto no data on hyperhomocyst(e)inaemia in children with renal failure have been published. Methods. We investigated 16 children with chronic renal failure on conservative management, 12 children on haemodialysis and 17 children with a renal transplant. Age-matched controls were used for comparison. Plasma homocyst(e)ine levels after an overnight fast were determined by HPLC. Glomerular filtration rate was estimated by the Schwartz formula. Results. Mean plasma homocyst(e)ine levels were 12.6 +/- 5.2 mu mol/l in the conservatively managed group, 22.2+/-13.5 mu mol/l in the haemodialysed group, 14.2+/-2.1 mu mol/l in transplanted children with an estimated GFR>60 ml/min/1.73 m(2) and 17.5+/-5.1 mu mol/l in transplanted children with a lower estimated GFR. Tn all groups homocyst(e)ine levels were significantly elevated as compared to controls. Homocyst(e)ine levels were significantly correlated with age and negatively correlated with estimated GFR and serum folate levels. Conclusions. Hyperhomocyst(e) inaemia is a feature of chronic renal failure in children as well as in adults. Elevated homocyst(e)ine levels can already be demonstrated in children with renal failure before end-stage renal disease has developed and persist after renal transplantation. Whether treatment of hyperhomocyst(e)inaemia in children with renal failure decreases the risk for future atherosclerosis remains to be proven.